|
124 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
11 Trials |
|
2428 News |
|
| «12...3132333435363738394041...4950» |
- lopinavir/ritonavir / Generic mfg.
Enrollment change, Monotherapy: BIOKAL: Analysis of Changes in Adipose Tissue of Patients With Lipoatrophy HIV Infection Treated With Nucleoside Thymidine, After Switching to Monotherapy With Lopinavir / Ritonavir (clinicaltrials.gov) - Apr 4, 2013
P4, N=7, Terminated, Sponsor: Ines Perez
N=30 --> 7
- Trial completion: HIV Prevention Intervention for Couples (clinicaltrials.gov) - Apr 4, 2013
P2, N=780, Completed, Sponsor: National Development and Research Institutes, Inc.
N=30 --> 7 Recruiting --> Completed
- || Isentress (raltegravir) / Merck (MSD)
New P3 trial: Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy (clinicaltrials.gov) - Apr 3, 2013
P3, N=1800, Recruiting, Sponsor: Anna Griffiths, MRC
- Trial completion: Effects of L-Carnitine on Postprandial Clearance of Triglyceride-rich Lipoproteins in HIV Patients on HAART (clinicaltrials.gov) - Apr 3, 2013
P=N/A, N=13, Completed, Sponsor: University of California, Davis
Recruiting --> Completed Recruiting --> Completed
- Twinrix (inactivated hepatitis A and recombinant hepatitis B) / GSK
Trial completion: Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder (clinicaltrials.gov) - Apr 3, 2013
P2, N=236, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: HNP: Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their Children (clinicaltrials.gov) - Apr 2, 2013
P=N/A, N=808, Completed, Sponsor: Indiana University School of Health & Rehabilitation Sciences
Active, not recruiting --> Completed N=450 --> 808
- Clinical guideline, Trial completion: Assessment of the Effectiveness of New Clinical Guidelines for Differential Diagnosis and Management of Common HIV/AIDS-related Conditions in Mozambique (clinicaltrials.gov) - Apr 2, 2013
P=N/A, N=492, Completed, Sponsor: Vanderbilt University
N=450 --> 808 Recruiting --> Completed
- Trial completion: HNP: Nutrition Intervention in Drug Naive HIV-infected Kenyan Women and Their Children (clinicaltrials.gov) - Apr 2, 2013
P=N/A, N=808, Completed, Sponsor: Indiana University School of Health & Rehabilitation Sciences
Recruiting --> Completed Recruiting --> Completed
- | Enrollment open: A Study to Investigate the Efficacy, Safety and Tolerability of PEG in Patients With Genital Herpes (clinicaltrials.gov) - Apr 1, 2013
P2, N=25, Recruiting, Sponsor: Devirex AG
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed: Effectiveness of Antiretroviral Therapy During Acute HIV Infection (clinicaltrials.gov) - Apr 1, 2013
P1, N=36, Active, not recruiting, Sponsor: Massachusetts General Hospital
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- ||||| Daklinza (daclatasvir) / BMS
Trial initiation date, IO biomarker: Safety and Efficacy Study of Daclatasvir (BMS-790052) Plus Pegylated Interferon-Alfa 2a and Ribavirin in Patients Coinfected With Untreated Hepatitis C Virus and HIV Virus (clinicaltrials.gov) - Mar 27, 2013
P3, N=300, Active, not recruiting, Sponsor: Bristol-Myers Squibb
Recruiting --> Active, not recruiting Initiation date: Oct 2010 --> Dec 2011
- zidovudine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Trial withdrawal, Combination therapy: A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects (clinicaltrials.gov) - Mar 26, 2013
P2, N=0, Withdrawn, Sponsor: RFS Pharma, LLC
Initiation date: Oct 2010 --> Dec 2011 Not yet recruiting --> Withdrawn
- zidovudine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Enrollment change, Combination therapy: A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects (clinicaltrials.gov) - Mar 26, 2013
P2, N=0, Withdrawn, Sponsor: RFS Pharma, LLC
Not yet recruiting --> Withdrawn N=30 --> 0
- | tenofovir disoproxil fumarate / Generic mfg., zidovudine / Generic mfg.
Enrollment closed, Combination therapy: A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects. (clinicaltrials.gov) - Mar 26, 2013
P2a, N=45, Active, not recruiting, Sponsor: RFS Pharma, LLC
N=30 --> 0 Recruiting --> Active, not recruiting
- | Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe
New P1 trial: Pharmacokinetic Interactions Between Telaprevir and Un-boosted Atazanavir (clinicaltrials.gov) - Mar 25, 2013
P1, N=14, Completed, Sponsor: Hospitales Universitarios Virgen del Roc
- Enrollment closed: Affect Management for Early Adolescents (clinicaltrials.gov) - Mar 25, 2013
P2, N=432, Active, not recruiting, Sponsor: Rhode Island Hospital
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Trial completion: Sleep, HIV Disease Progression, and Function in HIV Infected Children and Adolescents (clinicaltrials.gov) - Mar 25, 2013
P=N/A, N=90, Completed, Sponsor: Baylor College of Medicine
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial withdrawal: Garlic in Hyperlipidemia Caused by HAART (clinicaltrials.gov) - Mar 20, 2013
P2, N=0, Withdrawn, Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
Active, not recruiting --> Completed Terminated --> Withdrawn
- Enrollment change: Garlic in Hyperlipidemia Caused by HAART (clinicaltrials.gov) - Mar 20, 2013
P2, N=0, Withdrawn, Sponsor: National Center for Complementary and Alternative Medicine (NCCAM)
Terminated --> Withdrawn N=146 --> 0
- |||| lopinavir/ritonavir / Generic mfg.
Trial completion, Monotherapy: PEKARI: Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r (clinicaltrials.gov) - Mar 20, 2013
P4, N=68, Completed, Sponsor: Fundacion SEIMC-GESIDA
N=146 --> 0 Active, not recruiting --> Completed
- |||| abacavir/lamivudine/lopinavir/ritonavir (ABC/3TC/LPV/r) / Cipla, DNDi
Trial completion, Monotherapy: KRETA: Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy (clinicaltrials.gov) - Mar 20, 2013
P4, N=88, Completed, Sponsor: Fundacion SEIMC-GESIDA
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ritonavir / Generic mfg., lopinavir/ritonavir / Generic mfg.
Enrollment change, HEOR, Monotherapy: QoLKAMON: Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor (clinicaltrials.gov) - Mar 18, 2013
P4, N=228, Completed, Sponsor: Sociedad Andaluza de Enfermedades Infecciosas
Active, not recruiting --> Completed N=390 --> 228
- Enrollment change, Adverse events: A Mindfulness Based Approach to HIV Treatment Side Effects (clinicaltrials.gov) - Mar 18, 2013
P1/2, N=76, Completed, Sponsor: University of California, San Francisco
N=390 --> 228 N=100 --> 76
- Isentress (raltegravir) / Merck (MSD)
Enrollment open: Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP) (clinicaltrials.gov) - Mar 18, 2013
P4, N=240, Recruiting, Sponsor: Hospital Clinic of Barcelona
N=100 --> 76 Not yet recruiting --> Recruiting
- ritonavir / Generic mfg., lopinavir/ritonavir / Generic mfg.
Trial completion, HEOR, Monotherapy: QoLKAMON: Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor (clinicaltrials.gov) - Mar 18, 2013
P4, N=228, Completed, Sponsor: Sociedad Andaluza de Enfermedades Infecciosas
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- famciclovir / Generic mfg.
Trial completion: Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes (clinicaltrials.gov) - Mar 18, 2013
P=N/A, N=42, Completed, Sponsor: Holdsworth House Medical Practice
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Adverse events: A Mindfulness Based Approach to HIV Treatment Side Effects (clinicaltrials.gov) - Mar 18, 2013
P1/2, N=76, Completed, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Vaxigrip (inactivated influenza vaccine (split virion)) / Sanofi
New P4 trial: Immunogenicity and Safety of Trivalent Influenza Vaccine in Non-pregnant HIV-infected Women (clinicaltrials.gov) - Mar 14, 2013
P4, N=105, Completed, Sponsor: University of Witwatersrand, South Africa
- | Isentress (raltegravir) / Merck (MSD)
Trial completion: REAL: Raltegravir as Early Therapy in African-Americans Living With HIV Study (clinicaltrials.gov) - Mar 14, 2013
P4, N=43, Completed, Sponsor: David A Wohl, MD
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Tivicay (dolutegravir) / ViiV Healthcare
Trial completion: A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects (clinicaltrials.gov) - Mar 13, 2013
P1, N=24, Completed, Sponsor: ViiV Healthcare
Active, not recruiting --> Completed Recruiting --> Completed
- |||| lopinavir/ritonavir / Generic mfg.
Trial completion: Safety and Efficacy of Kaletra in ARV Therapy Experienced Patients (clinicaltrials.gov) - Mar 13, 2013
P4, N=207, Completed, Sponsor: AbbVie (prior sponsor, Abbott)
Recruiting --> Completed Terminated --> Completed
- Trial completion: Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners (clinicaltrials.gov) - Mar 12, 2013
P=N/A, N=598, Completed, Sponsor: University of North Carolina, Chapel Hill
Terminated --> Completed Recruiting --> Completed
- | efavirenz / Generic mfg., nevirapine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Enrollment change: PROMOTE-PEDS: HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children (clinicaltrials.gov) - Mar 10, 2013
P3, N=186, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed N=300 --> 186
- | efavirenz / Generic mfg., nevirapine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Trial completion: PROMOTE-PEDS: HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children (clinicaltrials.gov) - Mar 10, 2013
P3, N=186, Completed, Sponsor: University of California, San Francisco
N=300 --> 186 Recruiting --> Completed
- | trimethoprim/sulfamethoxazole / Generic mfg., artemether/lumefantrine / Generic mfg.
Trial completion: TCC: Interactions Between HIV and Malaria in African Children (clinicaltrials.gov) - Mar 10, 2013
P3, N=351, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Active, not recruiting --> Completed
- | Enrollment change: Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) (clinicaltrials.gov) - Mar 7, 2013
P3, N=2073, Active, not recruiting, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Active, not recruiting --> Completed N=1642 --> 2073
- Enrollment open: Screening, Brief Intervention, and Referral to Treatment for Offenders (clinicaltrials.gov) - Mar 7, 2013
P=N/A, N=800, Recruiting, Sponsor: University of California, Los Angeles
N=1642 --> 2073 Active, not recruiting --> Recruiting
- | trimethoprim/sulfamethoxazole / Generic mfg.
Trial completion: Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy (clinicaltrials.gov) - Mar 6, 2013
P3, N=848, Completed, Sponsor: Institute of Tropical Medicine, Belgium
Active, not recruiting --> Recruiting Active, not recruiting --> Completed
- trimethoprim/sulfamethoxazole / Generic mfg.
Trial termination: DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) (clinicaltrials.gov) - Mar 5, 2013
P3, N=48, Terminated, Sponsor: Immtech Pharmaceuticals, Inc
Active, not recruiting --> Completed Suspended --> Terminated; FDA Clinical Hold as of 12/21/07 due to safety concerns
- ||||| Incivek (telaprevir) / J&J, Vertex, Mitsubishi Tanabe
Trial initiation date: INSIGHT: An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) (clinicaltrials.gov) - Mar 5, 2013
P3, N=163, Active, not recruiting, Sponsor: Janssen-Cilag International NV
Suspended --> Terminated; FDA Clinical Hold as of 12/21/07 due to safety concerns Initiation date: Jan 2012 --> Apr 2012
- trimethoprim/sulfamethoxazole / Generic mfg.
Enrollment change: DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) (clinicaltrials.gov) - Mar 5, 2013
P3, N=48, Terminated, Sponsor: Immtech Pharmaceuticals, Inc
Initiation date: Jan 2012 --> Apr 2012 N=270 --> 48
- Enrollment open: Assessing the Safety of Dapivirine Gel and Film Formulations (clinicaltrials.gov) - Mar 5, 2013
P1, N=60, Recruiting, Sponsor: International Partnership for Microbicides, Inc.
N=270 --> 48 Not yet recruiting --> Recruiting
- Enrollment change: Motiv82Change: an HIV Prevention Study for Young Latino Men (clinicaltrials.gov) - Feb 28, 2013
P=N/A, N=200, Completed, Sponsor: Nova Southeastern University
Not yet recruiting --> Recruiting N=120 --> 200
- | GSK2838232 / GSK
New P1 trial: Single Dose Escalation Study of GSK2838232 in Healthy Subjects (clinicaltrials.gov) - Feb 28, 2013
P1, N=17, Completed, Sponsor: GlaxoSmithKline
- Vocabria (cabotegravir oral) / ViiV Healthcare
Enrollment change: Relative Bioavailability Study of GSK1265744 Formulations (clinicaltrials.gov) - Feb 27, 2013
P1, N=18, Completed, Sponsor: ViiV Healthcare
N=120 --> 200 N=24 --> 18
- | Vocabria (cabotegravir oral) / ViiV Healthcare
Trial completion: Relative Bioavailability Study of GSK1265744 Formulations (clinicaltrials.gov) - Feb 27, 2013
P1, N=18, Completed, Sponsor: ViiV Healthcare
N=24 --> 18 Active, not recruiting --> Completed
- Trial completion: An Automated, Tailored Information Application for Medication Health Literacy (clinicaltrials.gov) - Feb 27, 2013
P=N/A, N=124, Completed, Sponsor: Nova Southeastern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Selzentry (maraviroc) / ViiV Healthcare
Enrollment change: TROPISMVC: Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA (clinicaltrials.gov) - Feb 26, 2013
P2/3, N=58, Completed, Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
Active, not recruiting --> Completed N=28 --> 58
- | Selzentry (maraviroc) / ViiV Healthcare
Trial completion: TROPISMVC: Double-method Comparative Study in Order to Predict the Use of Co-receptors From Type 1 HIV: Phenotypic Study (Trofile ESTA (clinicaltrials.gov) - Feb 26, 2013
P2/3, N=58, Completed, Sponsor: Asociacion para el Estudio de las Enfermedades Infecciosas
N=28 --> 58 Recruiting --> Completed
- DNA-HIV-PT123 vaccine / EuroVacc, National Institute of Allergy and Infectious Diseases
New P1 trial: Evaluating the Safety and Priming Response of an HIV Vaccine Regimen in Healthy, HIV-Uninfected Adults (clinicaltrials.gov) - Feb 25, 2013
P1, N=96, Active, not recruiting, Sponsor: HIV Vaccine Trials Network